BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37973539)

  • 21. Increase of atypical fibroxanthoma and pleomorphic dermal sarcoma: a retrospective analysis of four German skin cancer centers.
    Kuntz T; Siebdrath J; Hofmann SC; Baltaci M; Schaller J; Hellmich M; von Goltzheim LS; Assaf C; Oellig F; Michalowitz AL; Helbig D; Kreuter A
    J Dtsch Dermatol Ges; 2022 Dec; 20(12):1581-1588. PubMed ID: 36442137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
    Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
    Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent atypical fibroxanthoma of the cheek.
    Skoulas IG; Price M; Andrew JE; Kountakis SE
    Am J Otolaryngol; 2001; 22(1):73-5. PubMed ID: 11172219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pleomorphic dermal sarcoma in a man with HIV: report with next-generation sequencing analysis and review of the atypical fibroxanthoma/pleomorphic dermal sarcoma spectrum.
    Chen SX; Eichenfield DZ; Orme C; Hinds B
    Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pleomorphic spindle cell dermal neoplasm with dot-like keratin reactivity: keratin-positive AFX or carcinoma?
    Ellis R; Chase E; Barland A; Rajpara A; Fraga GR
    J Cutan Pathol; 2015 Nov; 42(11):847-52. PubMed ID: 26041010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soft Tissue Special Issue: Cutaneous Pleomorphic Spindle Cell Tumors.
    Brenn T
    Head Neck Pathol; 2020 Mar; 14(1):109-120. PubMed ID: 31950467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma.
    Soleymani T; Tyler Hollmig S
    Curr Treat Options Oncol; 2017 Aug; 18(8):50. PubMed ID: 28762020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic utility of low-affinity nerve growth factor receptor (P 75) immunostaining in atypical fibroxanthoma.
    Bull C; Mirzabeigi M; Laskin W; Dubina M; Traczyc T; Guitart J; Gerami P
    J Cutan Pathol; 2011 Aug; 38(8):631-5. PubMed ID: 21623867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symbiotic collision tumour of the scalp: squamous cell carcinoma and malignant melanoma.
    Mangkorntongsakul V; Tng ETV; Scurry J; Gourlay R
    Australas J Dermatol; 2020 May; 61(2):e229-e230. PubMed ID: 31885076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical Fibroxanthoma.
    Chapman LW; Yu SS; Arron ST
    Semin Cutan Med Surg; 2019 Mar; 38(1):E65-E66. PubMed ID: 31051027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical fibroxanthoma with keloidal collagen.
    Fussell JN; Cooke ER; Florentino F; Sheehan DJ
    Am J Dermatopathol; 2010 Oct; 32(7):713-5. PubMed ID: 20700041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS).
    Helbig D; Ziemer M; Dippel E; Erdmann M; Hillen U; Leiter U; Mentzel T; Osterhoff G; Ugurel S; Utikal J; von Bubnoff D; Weishaupt C; Grabbe S
    J Dtsch Dermatol Ges; 2022 Feb; 20(2):235-243. PubMed ID: 35099104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma.
    Gleason BC; Calder KB; Cibull TL; Thomas AB; Billings SD; Morgan MB; Hiatt KM; Smoller BR
    J Cutan Pathol; 2009 May; 36(5):543-7. PubMed ID: 19476522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value.
    Monteagudo C; Calduch L; Navarro S; Joan-Figueroa A; Llombart-Bosch A
    Am J Clin Pathol; 2002 Jan; 117(1):126-31. PubMed ID: 11789717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Procollagen 1 expression in atypical fibroxanthoma and other tumors.
    Jensen K; Wilkinson B; Wines N; Kossard S
    J Cutan Pathol; 2004 Jan; 31(1):57-61. PubMed ID: 14675286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological and Genomic Profiles of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma Identify Overlapping Signatures with a High Mutational Burden.
    Ak M; Kahraman A; Arnold FM; Turko P; Levesque MP; Zoche M; Ramelyte E; Dummer R
    Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34202213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Keloidal and other collagen patterns in atypical fibroxanthomas.
    Offman S; Pasternak S; Walsh N
    Am J Dermatopathol; 2010 Jun; 32(4):326-32. PubMed ID: 20514669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical fibroxanthoma, rare and often unrecognized cutaneous soft tissue tumor - a case report and review of the literature.
    Čierna Z; Trška R
    Cesk Patol; 2019; 55(3):182-186. PubMed ID: 31726845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dermatoscopic features of cutaneous atypical fibroxanthoma: three cases.
    Bugatti L; Filosa G
    Clin Exp Dermatol; 2009 Dec; 34(8):e898-900. PubMed ID: 20055861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical staining of CD10 in atypical fibroxanthomas.
    Hultgren TL; DiMaio DJ
    J Cutan Pathol; 2007 May; 34(5):415-9. PubMed ID: 17448198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.